A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3R)BSC729.
The presence of P+PBac{XP5.RB3}BSC747 was verified using the PCR methods and primers described in FBrf0175003 with the substitution of the primer 5'-GCTTCTAAACGCTTACGCATAAACGATG-' for the RB3' plus or RB3' minus primer.
The cytological breakpoints of Df(3R)BSC747 predicted from the Release 5 genomic coordinates of PBac{RB}e02691 and P{XP}Pratd01596 insertion sites are 84D9;84E5.